The high prevalence of DICER1 mutations, especially in pediatric FTC cases, suggests a potential role for germline alterations leading to DICER1 syndrome, making it a crucial marker for family screening and preventive personalized medicine [18,20,25,26,27]. The gene discussed is DICER1; the disease is thyroid cancer, nonmedullary, 2.